iCAD (ICAD) Competitors

Electromed (NYSE:ELMD) and iCAD (NASDAQ:ICAD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, community ranking, earnings, risk, institutional ownership, profitability and dividends.

Is ELMD or ICAD more profitable?

Electromed has a net margin of 11.34% compared to iCAD's net margin of -17.81%. Electromed's return on equity of 15.71% beat iCAD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Electromed	11.34%	15.71%	13.37%
iCAD	-17.81%	-15.65%	-12.52%

Which has more risk and volatility, ELMD or ICAD?

Electromed has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Comparatively, iCAD has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500.

Do institutionals & insiders believe in ELMD or ICAD?

40.8% of Electromed shares are owned by institutional investors. Comparatively, 24.6% of iCAD shares are owned by institutional investors. 14.0% of Electromed shares are owned by company insiders. Comparatively, 10.3% of iCAD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Does the MarketBeat Community believe in ELMD or ICAD?

iCAD received 206 more outperform votes than Electromed when rated by MarketBeat users. However, 91.67% of users gave Electromed an outperform vote while only 60.80% of users gave iCAD an outperform vote.

Company	Underperform	Outperform
Electromed	Outperform Votes 22 91.67%	Underperform Votes 2 8.33%
iCAD	Outperform Votes 228 60.80%	Underperform Votes 147 39.20%

Do analysts rate ELMD or ICAD?

Electromed presently has a consensus price target of $38.00, indicating a potential upside of 66.74%. Given Electromed's stronger consensus rating and higher probable upside, research analysts plainly believe Electromed is more favorable than iCAD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Electromed	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	4.00
iCAD	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has preferable valuation and earnings, ELMD or ICAD?

Electromed has higher revenue and earnings than iCAD. iCAD is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Electromed	$59.63M	3.27	$5.15M	$0.75	30.39
iCAD	$19.61M	4.49	-$4.85M	-$0.21	-15.33

Does the media prefer ELMD or ICAD?

In the previous week, iCAD had 11 more articles in the media than Electromed. MarketBeat recorded 12 mentions for iCAD and 1 mentions for Electromed. Electromed's average media sentiment score of 1.52 beat iCAD's score of -0.03 indicating that Electromed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Electromed	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
iCAD	0 Very Positive mention(s)	4 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Electromed beats iCAD on 14 of the 18 factors compared between the two stocks.